118 related articles for article (PubMed ID: 8630967)
21. p18(INK4c) collaborates with other CDK-inhibitory proteins in the regenerating liver.
Luedde T; Rodriguez ME; Tacke F; Xiong Y; Brenner DA; Trautwein C
Hepatology; 2003 Apr; 37(4):833-41. PubMed ID: 12668976
[TBL] [Abstract][Full Text] [Related]
22. Lack of mutation in the cyclin-dependent kinase inhibitor, p19INK4d, in tumor-derived cell lines and primary tumors.
Zariwala M; Xiong Y
Oncogene; 1996 Nov; 13(9):2033-8. PubMed ID: 8934552
[TBL] [Abstract][Full Text] [Related]
23. The p19INK4D cyclin dependent kinase inhibitor gene is altered in osteosarcoma.
Miller CW; Yeon C; Aslo A; Mendoza S; Aytac U; Koeffler HP
Oncogene; 1997 Jul; 15(2):231-5. PubMed ID: 9244358
[TBL] [Abstract][Full Text] [Related]
24. Mutational analysis of the p16 family cyclin-dependent kinase inhibitors p15INK4b and p18INK4c in tumor-derived cell lines and primary tumors.
Zariwala M; Liu E; Xiong Y
Oncogene; 1996 Jan; 12(2):451-5. PubMed ID: 8570224
[TBL] [Abstract][Full Text] [Related]
25. Cell cycle regulators in bladder cancer: relationship to schistosomiasis.
Eissa S; Ahmed MI; Said H; Zaghlool A; El-Ahmady O
IUBMB Life; 2004 Sep; 56(9):557-64. PubMed ID: 15590562
[TBL] [Abstract][Full Text] [Related]
26. Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours.
Dahia PL; Aguiar RC; Honegger J; Fahlbush R; Jordan S; Lowe DG; Lu X; Clayton RN; Besser GM; Grossman AB
Oncogene; 1998 Jan; 16(1):69-76. PubMed ID: 9467944
[TBL] [Abstract][Full Text] [Related]
27. Parathyroid tumor suppressor on 1p: analysis of the p18 cyclin-dependent kinase inhibitor gene as a candidate.
Tahara H; Smith AP; Gaz RD; Zariwala M; Xiong Y; Arnold A
J Bone Miner Res; 1997 Sep; 12(9):1330-4. PubMed ID: 9286748
[TBL] [Abstract][Full Text] [Related]
28. Absence of p18 mutations or deletions in lymphoid malignancies.
Otsuki T; Jaffe ES; Wellmann A; Kumar S; Condron KS; Raffeld M
Leukemia; 1996 Feb; 10(2):356-60. PubMed ID: 8637248
[TBL] [Abstract][Full Text] [Related]
29. Alterations of the p15, p16,and p18 genes in osteosarcoma.
Miller CW; Aslo A; Campbell MJ; Kawamata N; Lampkin BC; Koeffler HP
Cancer Genet Cytogenet; 1996 Feb; 86(2):136-42. PubMed ID: 8603340
[TBL] [Abstract][Full Text] [Related]
30. Frequent inactivation of the cyclin-dependent kinase inhibitor p18 by homozygous deletion in multiple myeloma cell lines: ectopic p18 expression inhibits growth and induces apoptosis.
Kulkarni MS; Daggett JL; Bender TP; Kuehl WM; Bergsagel PL; Williams ME
Leukemia; 2002 Jan; 16(1):127-34. PubMed ID: 11840272
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the cyclin-dependent kinase inhibitors p18 and p19 in mantle-cell lymphoma and chronic lymphocytic leukemia.
Williams ME; Whitefield M; Swerdlow SH
Ann Oncol; 1997; 8 Suppl 2():71-3. PubMed ID: 9209645
[TBL] [Abstract][Full Text] [Related]
32. MTS1/p16/CDKN2 lesions in primary glioblastoma multiforme.
Moulton T; Samara G; Chung WY; Yuan L; Desai R; Sisti M; Bruce J; Tycko B
Am J Pathol; 1995 Mar; 146(3):613-9. PubMed ID: 7887443
[TBL] [Abstract][Full Text] [Related]
33. Antitumour effect of cyclin-dependent kinase inhibitors (p16(INK4A), p18(INK4C), p19(INK4D), p21(WAF1/CIP1) and p27(KIP1)) on malignant glioma cells.
Komata T; Kanzawa T; Takeuchi H; Germano IM; Schreiber M; Kondo Y; Kondo S
Br J Cancer; 2003 Apr; 88(8):1277-80. PubMed ID: 12698196
[TBL] [Abstract][Full Text] [Related]
34. Structural integrity of the cyclin-dependent kinase inhibitor genes, p15, p16 and p18 in myeloid leukaemias.
Nakamaki T; Kawamata N; Schwaller J; Tobler A; Fey M; Pakkala S; Lee YY; Kim BK; Fukuchi K; Tsuruoka N
Br J Haematol; 1995 Sep; 91(1):139-49. PubMed ID: 7577621
[TBL] [Abstract][Full Text] [Related]
35. Mutation and expression of the p27KIP1 and p57KIP2 genes in human gastric cancer.
Shin JY; Kim HS; Lee KS; Kim J; Park JB; Won MH; Chae SW; Choi YH; Choi KC; Park YE; Lee JY
Exp Mol Med; 2000 Jun; 32(2):79-83. PubMed ID: 10926119
[TBL] [Abstract][Full Text] [Related]
36. Intragenic mutations of the p16(INK4), p15(INK4B) and p18 genes in primary non-small-cell lung cancers.
Rusin MR; Okamoto A; Chorazy M; Czyzewski K; Harasim J; Spillare EA; Hagiwara K; Hussain SP; Xiong Y; Demetrick DJ; Harris CC
Int J Cancer; 1996 Mar; 65(6):734-9. PubMed ID: 8631583
[TBL] [Abstract][Full Text] [Related]
37. Homozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia.
Hatta Y; Hirama T; Miller CW; Yamada Y; Tomonaga M; Koeffler HP
Blood; 1995 May; 85(10):2699-704. PubMed ID: 7742529
[TBL] [Abstract][Full Text] [Related]
38. Analysis of the p16INK4A, p15INK4B and p18INK4C genes in multiple myeloma.
Tasaka T; Berenson J; Vescio R; Hirama T; Miller CW; Nagai M; Takahara J; Koeffler HP
Br J Haematol; 1997 Jan; 96(1):98-102. PubMed ID: 9012694
[TBL] [Abstract][Full Text] [Related]
39. Molecular analysis of the cyclin-dependent kinase inhibitor genes p15INK4b/MTS2, p16INK4/MTS1, p18 and p19 in human cancer cell lines.
Gemma A; Takenoshita S; Hagiwara K; Okamoto A; Spillare EA; McMemamin MG; Hussain SP; Forrester K; Zariwala M; Xiong Y; Harris CC
Int J Cancer; 1996 Nov; 68(5):605-11. PubMed ID: 8938142
[TBL] [Abstract][Full Text] [Related]
40. Molecular analysis of the cyclin-dependent kinase inhibitor genes, p15, p16, p18 and p19 in the myelodysplastic syndromes.
Nakamaki T; Bartram C; Seriu T; Kahan J; Fukuchi K; Tsuruoka N; Janssen JW; Miller CW; Koeffler HP
Leuk Res; 1997 Mar; 21(3):235-40. PubMed ID: 9111168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]